SEARCH

SEARCH BY CITATION

References

  • 1
    Perilongo G, Shafford E, Maibach R, Aronson D, Brugieres L, Brock P, et al. Risk-adapted treatment for childhood hepatoblastoma. Final report of the second study of the International Society of Paediatric Oncology—SIOPEL 2. Eur J Cancer 2004;40:411-421.
  • 2
    Brown J, Perilongo G, Shafford E, Keeling J, Pritchard J, Brock P, et al. Pretreatment prognostic factors for children with hepatoblastoma—results from the International Society of Paediatric Oncology (SIOP) study SIOPEL 1. Eur J Cancer 2000;36:1418-1425.
  • 3
    Perilongo G, Maibach R, Shafford E, Brugieres L, Brock P, Morland B, et al. Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma. N Engl J Med 2009;361:1662-1670.
  • 4
    Zsiros J, Maibach R, Shafford E, Brugieres L, Brock P, Czauderna P, et al. Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR study. J Clin Oncol 2010;28:2584-2590.
  • 5
    Wu F, Chen WZ, Bai J, Zou JZ, Wang ZL, Zhu H, et al. Pathological changes in human malignant carcinoma treated with high-intensity focused ultrasound. Ultrasound Med Biol 2001;27:1099-1106.
  • 6
    Wu F, Wang ZB, Chen WZ, Wang W, Gui Y, Zhang M, et al. Extracorporeal high intensity focused ultrasound ablation in the treatment of 1038 patients with solid carcinomas in China: an overview. Ultrason Sonochem 2004;11:149-154.
  • 7
    Benedict SH, De Meerleer G, Orton CG, Stancanello J. Point/counterpoint. High intensity focused ultrasound may be superior to radiation therapy for the treatment of early stage prostate cancer. Med Phys 2011;38:3909-3912.
  • 8
    Kasugai H, Kojima J, Tatsuta M, Okuda S, Sasaki Y, Imaoka S, et al. Treatment of hepatocellular carcinoma by transcatheter arterial embolization combined with intra-arterial infusion of a mixture of cisplatin and ethiodized oil. Gastroenterology 1989;97:965-971.
  • 9
    Jin C, Zhu H, Wang Z, Wu F, Chen W, Li K, et al. High-intensity focused ultrasound combined with transarterial chemoembolization for unresectable hepatocellular carcinoma: long-term follow-up and clinical analysis. Eur J Radiol 2011;80:662-669.
  • 10
    Schnater JM, Kohler SE, Lamers WH, von SD, Aronson DC. Where do we stand with hepatoblastoma? A review. Cancer 2003;98:668-678.
  • 11
    Bajpai M, Pal K, Agarwala S, Seth T, Gupta AK. Midterm results with hepatectomy after preoperative chemotherapy in hepatoblastoma. Pediatr Surg Int 2005;21:364-368.
  • 12
    Arcement CM, Towbin RB, Meza MP, Gerber DA, Kaye RD, Mazariegos GV, et al. Intrahepatic chemoembolization in unresectable pediatric liver malignancies. Pediatr Radiol 2000;30:779-785.
  • 13
    Ohtsuka Y, Matsunaga T, Yoshida H, Kouchi K, Okada T, Ohnuma N. Optimal strategy of preoperative transcatheter arterial chemoembolization for hepatoblastoma. Surg Today 2004;34:127-133.
  • 14
    Orsi F, Arnone P, Chen W, Zhang L. High intensity focused ultrasound ablation: a new therapeutic option for solid tumors. J Cancer Res Ther 2010;6:414-420.
  • 15
    Kennedy JE. High-intensity focused ultrasound in the treatment of solid tumours. Nat Rev Cancer 2005;5:321-327.
  • 16
    Kim HS, Baik JH, Pham LD, Jacobs MA. MR-guided high-intensity focused ultrasound treatment for symptomatic uterine leiomyomata: long-term outcomes. Acad Radiol 2011;18:970-976.
  • 17
    Jolesz FA, Hynynen K, McDannold N, Tempany C. MR imaging-controlled focused ultrasound ablation: a noninvasive image-guided surgery. Magn Reson Imaging Clin N Am 2005;13:545-560.
  • 18
    Gedroyc WM, Anstee A. MR-guided focused ultrasound. Expert Rev Med Devices 2007;4:539-547.
  • 19
    Wang S, Kong X-r, Yang C, Zhang J, Li C-c, Ouyang J, et al. Extracorporeal high intensity focused ultrasound treatment for a child with recurrence of hepatocellular carcinoma. Eur J Radiol Extra 2010;75:e101-e103.
  • 20
    Shen HP, Gong JP, Zuo GQ. Role of high-intensity focused ultrasound in treatment of hepatocellula rcarcinoma. Am Surg 2011;77:1496-1501.